Company · Toronto, Ontario, Canada
Bexco Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 4
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 2
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| BEXBLIS LIQ | 01975390 | Cancelled Post Market | |
| BEXPRIN PWR 333MG/GM | 00806323 | Cancelled Post Market | |
| CENTRAHEMO INJ | 01944215 | Cancelled Post Market | |
| HB INJECTION | 00807524 | Cancelled Post Market |
Notices of Compliance
Newest first.
- HY-50January 30, 2008 · NOC 9331 · Supplement to a New Drug Submission (SNDS)
- HY-50 INJECTIONAugust 14, 1998 · NOC 6761 · New Drug Submission (NDS)